๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Clear Cell Renal Cell Carcinoma

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell NCT07062549Phase 11 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: 111In-XYIMSR-01 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma NCT07067905EARLY Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: 68Ga-XT771 Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma NCT07223541Phase 21 site๐Ÿ“ Oklahoma City University of Oklahoma ยท Tests: Cemiplimab 350 MG Intravenous Solution, Fianlimab 1600 MG Intravenous Solution Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer NCT07234656n/a3 sites๐Ÿ“ Aalborg๐Ÿ“ Aarhus๐Ÿ“ Herning Brigitta Rasmussen Villumsen ยท Tests: Phase 1: Establishment of a patient-partner panel, Phase 2: Feasibility testing of FCR questions, mode of administratioโ€ฆ Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study NCT05361720Phase 26 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ Cleveland Vanderbilt-Ingram Cancer Center ยท Tests: Cabozantinib, Ipilimumab, Nivolumab Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma NCT06676527n/a1 site๐Ÿ“ Nanjing Jinling Hospital, China ยท Tests: Follow-up study of the treated cohort Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) NCT05931393Phase 21 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Cabozantinib 80 MG VSV-IFNฮฒ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma NCT07510334Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Nivolumab Imaging of Solid Tumors Using 18F-TRX NCT06942104Phase 11 site๐Ÿ“ San Francisco Rahul Aggarwal ยท Tests: 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy, Blood Specimen Collection A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors NCT06764771Phase 18 sites๐Ÿ“ Hackensack๐Ÿ“ Allentown๐Ÿ“ Germantown Bristol-Myers Squibb ยท Tests: BMS-986488, Adagrasib, Cetuximab, Nivolumab Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform NCT06868927n/a1 site๐Ÿ“ Milan IRCCS San Raffaele DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Alectinib A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma NCT07688187Phase 11 site๐Ÿ“ Omaha PeptiDream Inc. ยท Tests: PD-32766D (a Copper-64 [64Cu] labeled peptide), PD-32766T (an Actinium-225 [225Ac] labeled peptide) A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. NCT06903312Phase 41 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Deferred Cytoreductive Nephrectomy + medical treatment, Radiotherapy + medical treatment, Medical therapy A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034) NCT07489495Phase 3106 sites๐Ÿ“ Marietta๐Ÿ“ Louisville๐Ÿ“ Louisville Merck Sharp & Dohme LLC ยท Tests: Belzutifan, Zanzalintinib, Placebo A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases NCT05048212Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Nivolumab, Ipilimumab, Cabozantinib A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies NCT04923178n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC) NCT06005818Phase 21 site๐Ÿ“ Birmingham University of Alabama at Birmingham ยท Tests: Pembrolizumab injection TDM for Optimized Outcome in Patients With mRCC. NCT04659343n/a1 site๐Ÿ“ Aarhus Niels Fristrup ยท Tests: Measurement of concentration of active metabolite in cancer treatment. Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus NCT05319015Phase 21 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy, retroperitoneal lymph node diโ€ฆ A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig PET/MR for Characterization of Renal Masses (RMs) NCT06076538n/a2 sites๐Ÿ“ Dallas๐Ÿ“ Houston University of Texas Southwestern Medical Center ยท Tests: 2-Deoxy-2-[18F]fluoroglucose Positron Emission Tomography/Magnetic Resonance Imaging Radiopharmaceutical Treatment of Advanced Kidney Cancer NCT06783348Phase 22 sites๐Ÿ“ Caen๐Ÿ“ Villejuif European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: 177Lu-PSMA-617 National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC) NCT05326620n/a27 sites๐Ÿ“ Amsterdam๐Ÿ“ 's-Hertogenbosch๐Ÿ“ 's-Hertogenbosch PROspective Renal Cancer Cohort Foundation Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma NCT04053855n/a1 site๐Ÿ“ Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne ยท Tests: Urinary sample Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors NCT05768464Phase 22 sites๐Ÿ“ Nanjing๐Ÿ“ Nanning The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ ยท Tests: Toripalimab, Axitinib Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors NCT05868174Phase 15 sites๐Ÿ“ North Ryde๐Ÿ“ Adelaide๐Ÿ“ Brisbane Telix Pharmaceuticals (Innovations) Pty Limited ยท Tests: 89Zr-TLX250, 177Lu-TLX250 and Peposertib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy